Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...
In November 2024, Vaxcyte announced that the FDA granted Breakthrough Therapy designation to VAX-31 for the prevention of IPD in adults. The Breakthrough Therapy designation process is designed to ...
2022 Prevention Insurance.com Registered Shs 0.00 0.00 USD 2021 Prevention Insurance.com Registered Shs 0.00 0.00 USD 2020 Prevention Insurance.com Registered Shs 0.00 0.00 USD 2019 Prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback